Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 6th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG | $119.45 | -1.09% | 1.21% | 11.81% | 9.48% | 21.44% | 12.67% | 44.74% | 40.27% | 19.32% | $120.92 | $96.06 | 1.22% | 24.35% | 0.36 | 1,277,000 | 6.06% |
| JNJ | JOHNSON & JOHNSON | $157.10 | 0.28% | 1.34% | 5.83% | -3.61% | 7.15% | 8.01% | -8.03% | 11.22% | 61.14% | $169.99 | $140.68 | 7.58% | 11.67% | 0.26 | 6,588,000 | -6.90% |
| GRFS | GRIFOLS SA | $8.87 | -1.22% | 0.57% | 12.85% | 14.90% | 21.01% | 27.26% | -24.89% | -53.75% | -41.64% | $9.96 | $5.79 | 10.94% | 53.20% | 0.75 | 880,000 | 14.43% |
| ABBV | ABBVIE INC | $191.08 | -0.70% | 0.66% | 1.64% | -9.68% | 10.22% | 14.72% | 37.05% | 105.29% | 185.58% | $218.66 | $163.52 | 12.61% | 16.85% | 0.40 | 4,966,000 | -14.02% |
| AZN | ASTRAZENECA PLC | $74.42 | -0.77% | 2.11% | 9.89% | -2.73% | 11.78% | -6.43% | 24.01% | 41.38% | 129.02% | $87.68 | $61.24 | 15.12% | 21.52% | 0.44 | 3,132,000 | -9.11% |
| AMGN | AMGEN INC | $295.22 | -0.70% | 1.68% | 9.16% | -5.57% | 9.09% | -1.10% | 24.69% | 34.33% | 89.12% | $346.85 | $253.30 | 14.89% | 16.55% | 0.48 | 2,191,000 | 1.44% |
| GSK | GSK PLC | $40.86 | -3.84% | -0.83% | 12.41% | 4.15% | 20.35% | -0.61% | -23.09% | -19.72% | -22.45% | $44.67 | $31.72 | 8.53% | 28.83% | 0.38 | 7,659,000 | 115.20% |
| BMY | BRISTOL MYERS SQUIBB CO | $49.75 | -1.85% | 2.77% | 6.78% | -17.47% | -10.81% | 19.94% | -32.39% | -9.71% | -23.95% | $63.33 | $39.35 | 21.44% | 26.43% | 0.34 | 9,499,000 | -1.26% |
| LLY | ELI LILLY & CO | $819.36 | 0.90% | 6.43% | 9.82% | 2.21% | 3.83% | -7.24% | 181.30% | 478.97% | 874.50% | $972.53 | $677.09 | 15.75% | 21.01% | 0.60 | 2,755,000 | 21.31% |
| GILD | GILEAD SCIENCES INC | $109.98 | -1.85% | -2.21% | 8.43% | -2.97% | 19.73% | 73.03% | 85.93% | 48.68% | -6.92% | $119.96 | $62.69 | 8.32% | 75.45% | 0.42 | 8,149,000 | 16.46% |
| MRK | MERCK & CO INC | $81.71 | -0.13% | 3.47% | 6.63% | -13.73% | -19.89% | -36.84% | -3.87% | 10.39% | 43.05% | $134.63 | $73.31 | 39.31% | 11.46% | 0.32 | 14,551,000 | 10.49% |
| BIIB | BIOGEN INC | $130.65 | -1.25% | -1.86% | 6.08% | -6.67% | -12.92% | -44.13% | -32.01% | -53.09% | -66.35% | $238.00 | $110.04 | 45.11% | 18.73% | 0.77 | 1,207,000 | 5.14% |
| PFE | PFIZER INC | $24.54 | -1.21% | 5.10% | 7.30% | -4.14% | -4.07% | -11.25% | -48.78% | -26.44% | -27.91% | $31.54 | $20.92 | 22.19% | 17.33% | 0.42 | 46,360,000 | 9.21% |
| SNY | SANOFI | $49.67 | -2.28% | -1.59% | -0.58% | -13.99% | 6.13% | 4.50% | -0.50% | -1.82% | 0.47% | $60.12 | $45.80 | 17.38% | 8.45% | 0.36 | 2,304,000 | 18.28% |
| OGN | ORGANON & CO | $10.04 | -0.30% | 5.02% | 18.96% | -32.89% | -34.38% | -51.05% | -70.64% | N/A | N/A | $23.10 | $8.01 | 56.54% | 25.34% | 0.80 | 3,344,000 | -23.98% |
| SCLX | SCILEX HOLDING CO | $4.82 | -7.13% | -23.61% | 15.04% | -51.81% | -72.86% | -90.76% | -98.65% | N/A | N/A | $80.50 | $3.60 | 94.01% | 33.89% | 0.32 | 141,000 | -46.59% |
| AMRN | AMARIN CORP PLC | $13.25 | -0.97% | 4.17% | 29.02% | 61.59% | 45.51% | -17.72% | -61.03% | -90.33% | -72.62% | $16.37 | $7.08 | 19.04% | 87.15% | 1.10 | 120,000 | -3.23% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.21 | -2.42% | -13.57% | 2.54% | -3.20% | 8.04% | 70.42% | N/A | N/A | N/A | $5.01 | $0.51 | 75.85% | 137.25% | 1.73 | 79,500 | 16.91% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.